18F-deoxyglucose (FDG)

DRUG2 trials

Sponsors

Maastricht Radiation Oncology, Nantes University Hospital

Conditions

Lung CancerNSCLCPatients With Idiopathic Dilated CardiomyopathySCLC

Phase 3

Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation

TerminatedNCT00522639

Maastricht Radiation OncologyLung Cancer, NSCLC, SCLC

Start: 2008-10-31End: 2009-06-30Target: 120Updated: 2009-06-30

Unknown Phase

18F-deoxyglucose (FDG) PET-CMD

CompletedNCT02078141

Nantes University HospitalPatients With Idiopathic Dilated Cardiomyopathy

Start: 2014-06-24End: 2018-01-18Updated: 2022-07-26

Related Papers

Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer.

2013-09-0937 citations